$11.6MRound, 14 October 2025
Funds first EVerGel clinical trial in 2026 and GMP exosome production.
- Amount
- $11.6M
- Announced
- 14 October 2025
- Lead
- Capital Grand Est
- Other investors
- EIC Fund, Sorbonne Venture, Aloe Private Equity, Paris Business Angels
- Use of funds
- Funds first EVerGel clinical trial in 2026 and GMP exosome production.
- Checked
- Amount and date matched across 2 press sources
- Sources
- EVerZom raises €10M Venture siliconcanals.com
EVerZom raises €10M Venture funding.tech.eu